Back to Search Start Over

Pharmacological potential of sulfated polygalactopyranosyl-fucopyranan from the brown seaweed Sargassum wightii.

Authors :
Maneesh, Anusree
Chakraborty, Kajal
Source :
Journal of Applied Phycology; Jun2018, Vol. 30 Issue 3, p1971-1988, 18p
Publication Year :
2018

Abstract

A sulfated polygalactopyranosyl-fucopyranan characterized as ∙∙∙∙ → 1)-α-Fucp-(2SO<subscript>3</subscript><superscript>−</superscript>)-(3 → 1)-α-Fucp-(2SO<subscript>3</subscript><superscript>−</superscript>)-(4 → 1)-β-Galp-(4 → 1)-β-Galp-(4 → ∙∙∙∙ was isolated from the brown seaweed Sargassum wightii and evaluated for pharmacological properties with reference to antioxidant, anti-inflammatory, antidiabetic, and antihypertensive activities using different in vitro models. The sulfated polygalactopyranosyl-fucopyranan displayed potential di(phenyl)-(2,4,6-trinitrophenyl) iminoazanium (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS<superscript>+</superscript>) radical scavenging, and Fe<superscript>2+</superscript> ion chelating activities (IC<subscript>90</subscript> ~ 1 mg mL<superscript>−1</superscript>). The studied polysaccharide displayed higher anti-inflammatory selectivity towards inducive pro-inflammatory enzyme cyclooxygenase-2 (COX-2, IC<subscript>90</subscript> 1.13 mg mL<superscript>−1</superscript>) than constitutive cyclooxygenase-1 (COX-1, IC<subscript>90</subscript> > 1.20 mg mL<superscript>−1</superscript>) resulting in greater selectivity index (IC<subscript>90</subscript> COX-2/COX-1, 0.93) than synthetic non-steroidal anti-inflammatory drug aspirin (0.88) and also showed potent lipoxygenase-5 inhibition (LOX-5, IC<subscript>90</subscript> 1.02 mg mL<superscript>−1</superscript>). The studied polysaccharide displayed significantly higher (P < 0.05) antidiabetic properties compared to the antidiabetic agents acarbose and diprotein-A in terms of α-amylase (IC<subscript>90</subscript> 0.93 mg mL<superscript>−1</superscript>), α-glucosidase (IC<subscript>90</subscript> 1.48 mg mL<superscript>−1</superscript>), and dipeptidyl peptidase-4 (IC<subscript>90</subscript> 0.11 mg mL<superscript>−1</superscript>) enzyme inhibition potentials. The sulfated polygalactopyranosyl-fucopyranan also displayed potential antihypertensive activity with reference to angiotensin-converting enzyme-I inhibitory activity (IC<subscript>90</subscript> 0.2 mg mL<superscript>−1</superscript>). Extensive spectroscopic experiments in conjugation with monosaccharide compositional analysis attributed (1 → 3)-linked α-fucopyranose units in the polygalactofucan chain with C-2 sulfation and C-4 substituents as O-acetyl/O-methyl/(1 → 4)-linked β-galactopyranose. The previously undescribed sulfated polygalactopyranosyl-fucopyranan could function as a potential pharmacophore lead against inflammation, type 2 diabetics, hypertension and utilization as natural antioxidant. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09218971
Volume :
30
Issue :
3
Database :
Complementary Index
Journal :
Journal of Applied Phycology
Publication Type :
Academic Journal
Accession number :
129930216
Full Text :
https://doi.org/10.1007/s10811-017-1385-y